UB Paderborn / Katalog / Suche / in CDI

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 2021-02, Vol.19 (1), p.46-52

2021

Link zum Volltext

Verfügbarkeit prüfen

PS87. An update on prediction of treatment outcome in treatment resistant depression

The international journal of neuropsychopharmacology, 2016-06, Vol.19 (Suppl_1), p.30-30

2016

Link zum Volltext

Verfügbarkeit prüfen

PS75. Psychopharmacoepidemiology of Major Depressive Disorder in European Tertiary Psychiatric Treatment Centers

The international journal of neuropsychopharmacology, 2016-06, Vol.19 (Suppl_1), p.25-26

2016

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to “Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients.” [Progress in Neuro-Psychopharmacology & Biological Psychiatry 44 (2013) 271–278]

Progress in neuro-psychopharmacology & biological psychiatry, 2013-10, Vol.46, p.70-70

2013

Link zum Volltext

Verfügbarkeit prüfen

Chapter 10 - Switching antidepressants in patients with treatment-resistant depression

Managing Treatment-Resistant Depression, 2022, p.167-174

2022

Link zum Volltext

Verfügbarkeit prüfen

Switching antidepressants in patients with treatment-resistant depression

2022

Link zum Volltext

Verfügbarkeit prüfen

Dimensions of Delusions in Major Depression

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 2015-04, Vol.13 (1), p.48-52

2015

Link zum Volltext

Verfügbarkeit prüfen

The impact of catechol- O-methyltransferase (COMT) pharmacogenetics on treatment resistance in major depressive disorder detected by capillary electrophoresis

Toxicology letters, 2008-10, Vol.180, p.S120-S121

2008

Link zum Volltext

Verfügbarkeit prüfen

Definition criteria for treatment resistant depression

European psychiatry, 1998, Vol.13 (S4), p.206s-206s

Souery, Daniel

1998

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 42

Suche als RSS-Feed

Aktive Filter

KollektionNature

Zeitschrift / SerieAmerican Journal Of Medical Genetics

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(38)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

The sociodemographic and clinical phenotype of European patients with major depressive disorder undergoing first-line antidepressant treatment with NaSSAs

W68. A META-ANALYSIS OF POLYGENIC RISK SCORES FOR MOOD DISORDERS, NEUROTICISM, AND SCHIZOPHRENIA IN ANTIDEPRESSANT RESPONSE

PHARMACOGENETICS OF CYP2C19 IN RESPONSE AND SIDE EFFECTS TO MAJOR DEPRESSIVE DISORDER TREATMENT: A MACHINE LEARNING APPROACH

W29. METABOLIZING STATUS OF CYP2C19 IN ANTIDEPRESSANT RESPONSE AND SIDE EFFECTS: RESULTS FROM A NATURALISTIC STUDY

Differential efficacy of escitalopram and nortriptyline ondimensional measures of depression

CYP2D6 Revisited in GENDEP: Inter-Platform Concordance

WHOLE EXOME SEQUENCING REVEALS RISK FACTORS IN TREATMENT RESISTANT DEPRESSION

SU85 - WHOLE EXOME SEQUENCING REVEALS RISK FACTORS IN TREATMENT RESISTANT DEPRESSION

58 PREDICTION OF TREATMENT-RESISTANT DEPRESSION USING EXOME SEQUENCE AND GENOME-WIDE DATA

M74 HIGHER POLYGENIC RISK SCORES FOR SCHIZOPHRENIA MAY BE SUGGESTIVE OF NON-RESPONSE TO DRUGS FOR DEPRESSION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER

F93. CYP2D6 Revisited in GENDEP, a Multicenter Clinical Trial of Nortriptyline and Escitalopram

SA84 - PLEIOTROPIC GENES IN PSYCHIATRY: EFFECTS OF CALCIUM CHANNELS AND THE STRESS-RELATED FKBP5 GENE ON ANTIDEPRESSANT RESPONSE AND TREATMENT RESISTANCE

PLEIOTROPIC GENES IN PSYCHIATRY: EFFECTS OF CALCIUM CHANNELS AND THE STRESS-RELATED FKBP5 GENE ON ANTIDEPRESSANT RESPONSE AND TREATMENT RESISTANCE

F128TRANSDIAGNOSTIC EFFECT ON PSYCHOPATHOLOGY BY PSYCHOSES GENES VARIANTS

SA105A GENOME-WIDE ASSOCIATION STUDY OF TREATMENT-RESISTANT DEPRESSION AND META-ANALYSIS OF THREE INDEPENDENT SAMPLES

Possible Modulatory Role of ARC Gene Variants in Mood Disorders

PS87. An update on prediction of treatment outcome in treatment resistant depression

PS75. Psychopharmacoepidemiology of Major Depressive Disorder in European Tertiary Psychiatric Treatment Centers

Corrigendum to “Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients.” [Progress in Neuro-Psychopharmacology & Biological Psychiatry 44 (2013) 271–278]

Genetic Predictors of Response to Serotonergic and Noradrenergic Antidepressants in Major Depressive Disorder: A Genome-Wide Analysis of Individual-Level Data and a Meta-Analysis: e1001326

Chapter 10 - Switching antidepressants in patients with treatment-resistant depression

Switching antidepressants in patients with treatment-resistant depression

Dimensions of Delusions in Major Depression

The impact of catechol- O-methyltransferase (COMT) pharmacogenetics on treatment resistance in major depressive disorder detected by capillary electrophoresis

Definition criteria for treatment resistant depression

Aktive Filter

Suchergebnisse filtern